Log in

OTCMKTS:ARYBULegend Biotech Stock Price, Forecast & News

$11.59
-0.06 (-0.52 %)
(As of 07/1/2020 04:00 PM ET)
Add
Compare
Today's Range
$11.13
Now: $11.59
$11.75
50-Day Range N/A
52-Week Range
$10.50
Now: $11.59
$11.77
Volume16,000 shs
Average Volume93,567 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
ARYA Sciences Acquisition Corp II operates as a blank check company. The company is based in Cayman Islands.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.00 out of 5 stars


Industry, Sector and Symbol

Industry Shell Companies
Sub-IndustryN/A
Current SymbolOTCMKTS:ARYBU
CUSIPN/A
CIKN/A
WebN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive ARYBU News and Ratings via Email

Sign-up to receive the latest news and ratings for ARYBU and its competitors with MarketBeat's FREE daily newsletter.

Legend Biotech (OTCMKTS:ARYBU) Frequently Asked Questions

Has Legend Biotech been receiving favorable news coverage?

Headlines about ARYBU stock have trended very negative on Thursday, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Legend Biotech earned a news impact score of -3.3 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term. View the latest news about Legend Biotech.

Who are some of Legend Biotech's key competitors?

Who are Legend Biotech's key executives?

Legend Biotech's management team includes the following people:
  • Mr. Adam Leo Stone, CEO & Director (Age 41)
  • Mr. Michael Seth Altman C.F.A., CFA, CFO & Director (Age 38)

What is Legend Biotech's stock symbol?

Legend Biotech trades on the OTCMKTS under the ticker symbol "ARYBU."

When does Legend Biotech's quiet period expire?

Legend Biotech's quiet period expires on Wednesday, July 15th. Legend Biotech had issued 13,000,000 shares in its initial public offering on June 5th. The total size of the offering was $130,000,000 based on an initial share price of $10.00. During Legend Biotech's quiet period, underwriters and any insiders that worked on the IPO are restricted from issuing any research reports or earnings estimates for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

How do I buy shares of Legend Biotech?

Shares of ARYBU can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Legend Biotech's stock price today?

One share of ARYBU stock can currently be purchased for approximately $11.59.

This page was last updated on 7/2/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.